keine Finanzberatung

ZBH · Zimmer Biomet

Orthopedic implants — hips, knees, sports medicine

Risiko 4/10 · LOW-MODERATE RISK · slow-growth medtech · $98.07 ▼ 0.86%Von KI geschrieben

Stand der Zahlen: · Quellen: öffentliche Markt-Aggregatoren

Kennzahlen

  • Price $98.07
  • Market cap $18.7B
  • P/E (ttm) 23.8
  • Div yield 0.98%
  • 52-wk range $79.12 – $106.88
  • Index rank #404 / —

Wichtigste Risiken

  • Growth stays stuck in low single digits as Stryker takes share (Shareholders) — MED
  • Hospital and payer pricing pressure on implants (Shareholders) — MED
  • Product recalls and orthopedic liability litigation (Customers) — MED
  • Restructuring programs that never quite deliver the margin (Shareholders) — LOW

Fazit

Cheap and steady, but a show-me story until growth accelerates — moderate risk, modest reward.

Interaktive Analyse öffnen →

Recherche, keine Anlageberatung.

⚠️ Independent research for a video, not financial advice. Figures from public sources/aggregators, can be stale; risk scores are editorial estimates. Verify before relying on any of it.